Published guidance, NICE advice and quality standards | Guidance

Showing 241 to 250 of 291

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer	TA263	22 August 2012	22 August 2012
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer that overexpresses HER2	TA257	27 June 2012	27 June 2012
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer	TA258	27 June 2012	27 June 2012
Focal therapy using cryoablation for localised prostate cancer	HTG284	26 April 2012	26 April 2012
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy	TA242	25 January 2012	25 January 2012
Breast reconstruction using lipomodelling after breast cancer treatment	HTG280	23 January 2012	23 January 2012
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer	TA118	24 January 2007	1 January 2012
Fulvestrant for the treatment of locally advanced or metastatic breast cancer	TA239	14 December 2011	14 December 2011
Laparoscopic cryotherapy for renal cancer	HTG271	24 August 2011	24 August 2011
Percutaneous cryotherapy for renal cancer	HTG269	27 July 2011	27 July 2011